Walkner Condon Financial Advisors LLC Abb Vie Inc. Transaction History
Walkner Condon Financial Advisors LLC
- $459 Million
- Q2 2024
A detailed history of Walkner Condon Financial Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Walkner Condon Financial Advisors LLC holds 1,694 shares of ABBV stock, worth $313,661. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,694
Previous 2,693
37.1%
Holding current value
$313,661
Previous $490,000
40.82%
% of portfolio
0.06%
Previous 0.11%
Shares
10 transactions
Others Institutions Holding ABBV
# of Institutions
3,647Shares Held
1.23BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$31.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$26.5 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$14.4 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$9.49 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.91 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $327B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...